The Cerbat Gem logo

The Latest Headlines at The Cerbat Gem

Image about LifeMD (NASDAQ:LFMD) Releases Earnings Results, Beats Expectations By $0.42 EPS

LifeMD (NASDAQ:LFMD) Releases Earnings Results, Beats Expectations By $0.42 EPS

LifeMD (NASDAQ:LFMD – Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.42, FiscalAI... More of this article »
Image about Top Pharmaceutical Stocks To Add to Your Watchlist – March 9th

Top Pharmaceutical Stocks To Add to Your Watchlist – March 9th

Eli Lilly and Company, AbbVie, and Abbott Laboratories are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are shares of publicly traded companies involved... More of this article »
Image about Hewlett Packard Enterprise (NYSE:HPE) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Hewlett Packard Enterprise (NYSE:HPE) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Hewlett Packard Enterprise (NYSE:HPE – Get Free Report) released its earnings results on Monday. The technology company reported $0.65 EPS for the quarter, topping analysts’ consensus estimates of $0.60 by $0.05, FiscalAI... More of this article »
Image about UBS Group Lowers Baldwin Insurance Group (NASDAQ:BWIN) Price Target to $40.00

UBS Group Lowers Baldwin Insurance Group (NASDAQ:BWIN) Price Target to $40.00

Baldwin Insurance Group (NASDAQ:BWIN – Get Free Report) had its price objective lowered by equities research analysts at UBS Group from $44.00 to $40.00 in a research note issued to investors on Monday,Benzinga reports. The... More of this article »
Image about UBS Group Issues Positive Forecast for Agree Realty (NYSE:ADC) Stock Price

UBS Group Issues Positive Forecast for Agree Realty (NYSE:ADC) Stock Price

Agree Realty (NYSE:ADC – Get Free Report) had its price objective lifted by stock analysts at UBS Group from $82.00 to $91.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “buy”... More of this article »
Image about Insider Selling: Teva Pharmaceutical Industries (NYSE:TEVA) Insider Sells 1,127 Shares of Stock

Insider Selling: Teva Pharmaceutical Industries (NYSE:TEVA) Insider Sells 1,127 Shares of Stock

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) insider Brian Savage sold 1,127 shares of Teva Pharmaceutical Industries stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an... More of this article »
Image about Qualcomm (NASDAQ:QCOM) Trading 1.8% Higher   – Here’s What Happened

Qualcomm (NASDAQ:QCOM) Trading 1.8% Higher – Here’s What Happened

Qualcomm Incorporated (NASDAQ:QCOM – Get Free Report) shot up 1.8% during mid-day trading on Monday . The stock traded as high as $138.58 and last traded at $138.11. 12,288,600 shares changed hands during mid-day trading, an... More of this article »
Image about Rivian Automotive (NASDAQ:RIVN) Stock Price Up 3.3%  – Should You Buy?

Rivian Automotive (NASDAQ:RIVN) Stock Price Up 3.3% – Should You Buy?

Rivian Automotive, Inc. (NASDAQ:RIVN – Get Free Report)’s share price traded up 3.3% during trading on Monday . The company traded as high as $15.97 and last traded at $15.87. 24,379,741 shares changed hands during trading,... More of this article »
Image about Exact Sciences (NASDAQ:EXAS) Sets New 12-Month High  – Should You Buy?

Exact Sciences (NASDAQ:EXAS) Sets New 12-Month High – Should You Buy?

Exact Sciences Corporation (NASDAQ:EXAS – Get Free Report)’s share price reached a new 52-week high during trading on Monday . The company traded as high as $103.75 and last traded at $103.71, with a volume of 3185358 shares... More of this article »
Image about Alpha Architect 1-3 Month Box ETF (BATS:BOXX) Reaches New 1-Year High  – Here’s What Happened

Alpha Architect 1-3 Month Box ETF (BATS:BOXX) Reaches New 1-Year High – Here’s What Happened

Alpha Architect 1-3 Month Box ETF (BATS:BOXX – Get Free Report) shares hit a new 52-week high on Monday . The stock traded as high as $115.89 and last traded at $115.89, with a volume of 1591355 shares changing hands. The stock... More of this article »
Image about JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ:JEPQ) Trading Up 1.3%  – Should You Buy?

JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ:JEPQ) Trading Up 1.3% – Should You Buy?

JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ:JEPQ – Get Free Report) shares traded up 1.3% on Monday . The company traded as high as $57.68 and last traded at $57.58. 10,878,901 shares changed hands during trading, an increase... More of this article »
Image about NET Power (NYSE:NPWR) Issues Quarterly Earnings Results

NET Power (NYSE:NPWR) Issues Quarterly Earnings Results

NET Power (NYSE:NPWR – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.04), FiscalAI reports. NET... More of this article »
Image about Freightcar America (NASDAQ:RAIL) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Freightcar America (NASDAQ:RAIL) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Freightcar America (NASDAQ:RAIL – Get Free Report) posted its quarterly earnings results on Monday. The transportation company reported $0.16 earnings per share for the quarter, missing analysts’ consensus estimates of... More of this article »
Image about Gold Stocks To Consider – March 9th

Gold Stocks To Consider – March 9th

Freeport-McMoRan, Newmont, First Majestic Silver, Barrick Mining, Coeur Mining, Agnico Eagle Mines, and Kinross Gold are the seven Gold stocks to watch today, according to MarketBeat’s stock screener tool. Gold stocks are shares... More of this article »
Image about Design Therapeutics (NASDAQ:DSGN) Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Design Therapeutics (NASDAQ:DSGN) Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Design Therapeutics (NASDAQ:DSGN – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.27) EPS for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.10, FiscalAI... More of this article »